- Dec 19, 2014
NCT02076009: Phase 3 - Daratumumab, Lenalidomide & Dex (DRd) VS Len & Dexa (Rd) - MMY3003 (POLLUX)
MMY3003 (POLLUX) Study NCT02076009: Phase 3: A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and...
374
- Dec 18, 2014
Myeloma UK - Myeloma Animations Series: High Dose Therapy and Autologous Stem Cell Transplantation
Myeloma UK - Myeloma Animations High Dose Therapy and Autologous Stem Cell Transplantation Learn More: https://www.myeloma.org.uk/
61
- Dec 18, 2014
14th International Myeloma Workshop: April 3rd-7th, 2013 Kyoto, Japan
14th International Myeloma Workshop April 3rd-7th, 2013 Kyoto, Japan https://www.myelomasociety.org/publications/ 14th IMW Abstract Book:...
116
- Dec 18, 2014
Charlotte Radiology: Port Placement: Dr. Eric Wang
Charlotte Radiology: Port Placement: Dr. Eric Wang
133
- Dec 17, 2014
NCT02197221: Phase 3: Bortezomib-Melphalan Conditioning Regimen vs Melphalan - Frontline Transplant
IFM2014-02 NCT02197221: Phase 3: Bortezomib-Melphalan Conditioning Regimen vs Melphalan for Frontline Transplant Eligible Patients With...
71
- Dec 17, 2014
NCT02119468: Phase 1/2: Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With RRMM
NCT02119468: Phase 1/2: Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple...
41